Browsing by Author "Tabernero, Josep"
Now showing items 1-20 of 21
-
A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials
Bareche, Yacine; Abbas-Aghababazadeh, Farnoosh; Lo Giacco, Deborah; Martin Casado, Agatha; Saavedra Gadea, Omar; Berche, Roger; Mirallas, Oriol; Jimenez, Jose; Valverde Morales, Claudia Maria; Díez García, Marc; Hernando-Calvo, Alberto; Vila-Casadesús, Maria; Gonzalez Medina, Alberto; Brana, Irene; Vieito , Maria; fasani, roberta; Mancuso, Francesco Mattia; Saoudi Gonzalez, Nadia; Suárez, Cristina; Elez, Elena; Capdevila Castillon, Jaume; OAKNIN, ANA; Saura Manich, Cristina; Macarulla, Teresa; Carles, Joan; FELIP, ENRIQUETA; Nuciforo, Paolo; Seoane, Joan; Tabernero, Josep; GARRALDA, Elena; Vivancos, Ana; MUÑOZ COUSELO, EVA; Dienstmann, Rodrigo (Elsevier, 2023-10-13) -
A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer
Van Cutsem, Eric; GARRALDA, Elena; Tai, David; de Braud, Filippo Guglielmo Maria; Geva, Ravit; Elez, Elena ; Tabernero, Josep (Oxford University Press, 2023-03) -
A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)
Argilés Martinez, Guillem; Mulet Margalef, Nuria; Valladares-Ayerbes, Manuel; Viéitez, Jose Maria; Grávalos, Cristina; García-Alfonso, Pilar; Tabernero, Josep (Elsevier, 2022-12) -
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
Tempero, Margaret; Pelzer, Uwe; O'Reilly, Eileen M.; Winter, Jordan; OH, DO-YOUN; Li, Chung-Pin; Tabernero, Josep (American Society of Clinical Oncology, 2023-04-10) -
Antitumor activity of lurbinectedin in combination with oral capecitabine in patients with metastatic breast cancer
Awada, Ahmad; Moreno, Victor; Aftimos, Philippe; Kahatt, Carmen; Luepke Estefan, Xarles Erik; Boni, Valentina; Tabernero, Josep (Elsevier, 2022-12) -
Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAFV600E-Mutant Colorectal Cancer
Woods, Melanie; Lee, Hey Min; De Falco, Vincenzo; MARTINI, Giulia; Della Corte, Carminia Maria; Napolitano, Stefania; Tabernero, Josep (American Association for Cancer Research, 2023-06-15) -
Early-Stage Breast Cancer Detection in Breast Milk
Ortiz Velez, Carolina; Martin Casado, Agatha; Martínez-Sabadell, Alex; Garcia-Ruiz, Itziar; Miranda, Ignacio; Morales Comas, Clara; Viaplana, Cristina; Bayó Puxan, Neus; Miquel Aymar, Josep Maria; Gómez-Rey, Marina; Sanso, Miriam; Saura Manich, Cristina; Matito, Judit; ARENAS LAHUERTA, ENRIQUE JAVIER; Suñol-Camas, Anna; Carrasco Lopez, Estela; Peg, Vicente; Nuciforo, Paolo; Gonzalez Medina, Alberto; Villacampa Javierre, Guillermo; Arévalo Martínez, Silvia; Espinosa-Bravo, Martin; Balmaña, Judith; Arribas, Joaquin; Tabernero, Josep; Vivancos, Ana; Dienstmann, Rodrigo (American Association for Cancer Research, 2023-10-01) -
Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer
MARTINI, Giulia; belli, valentina; Napolitano, Stefania; Ciaramella, Vincenza; ciardiello, davide; Belli, Andrea; Puig Borreil, Isabel; Ramírez Corpas, Lorena; Chicote Ramos, Irene; Mancuso, Francesco Mattia; Caratù, Ginevra; Serres-Créixams, Xavier; fasani, roberta; Jiménez Flores, José Antonio; Ros, Javier; Baraibar, Iosune; Vivancos, Ana; Elez, Elena ; Palmer, Hector; Argilés Martinez, Guillem; Tabernero, Josep; Dienstmann, Rodrigo (Elsevier, 2023-06) -
GDF15 Is an Eribulin Response Biomarker also Required for Survival of DTP Breast Cancer Cells
Bellio, Chiara; Emperador, Marta; Castellano Escuder, Pol; Gris Oliver, Albert; Canals Suris, Francesc; Sánchez Pla, Alex; Serra, Violeta; Zamora, Esther; Arribas, Joaquin; Saura, Cristina; Tabernero, Josep; Villanueva Cardús, Josep (MDPI, 2022-05-23) -
Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers
Ros, Javier; Baraibar, Iosune; Saoudi Gonzalez, Nadia; R Castells, Marta; Salvà, Francesc; Tabernero, Josep; Elez, Elena (MDPI, 2023-08-24) -
Liver transplantation in metastatic colorectal cancer: are we ready for it?
Salvà, Francesc; DOPAZO, CRISTINA; López, Daniel; Saoudi Gonzalez, Nadia; Charco, Ramon; Ros, Javier; Baraibar, Iosune; Tabernero, Josep; Elez, Elena (Springer Nature, 2023-05) -
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy
Linares, Jenniffer; Sallent-Aragay, Anna; Badia-Ramentol, Jordi; Recort-Bascuas, Alba; Méndez, Ana; Manero-Rupérez, Noemí; Saoudi Gonzalez, Nadia; Elez, Elena; Tabernero, Josep (Nature Portfolio, 2023-02-10) -
PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system
Zimmer, Kai; Kocher, Florian; Untergasser, Gerold; Kircher, Brigitte; Amann, Arno; Baca, Yasmine; Macarulla, Teresa; Tabernero, Josep (Nature Portfolio, 2023-07-03) -
Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma
Rüschoff, Josef; Lolkema, Martijn; GIANNI, LUCA; Voest, Emile; de Vries, Elisabeth; Tabernero, Josep (Wiley, 2023-06) -
Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments
Matito, Judit; Comas Navarro, Raquel; García, Ariadna I.; MARTINI, Giulia; Martin, Anne Marie; Ros, Javier; Villacampa Javierre, Guillermo; Baraibar, Iosune; Saoudi Gonzalez, Nadia; Salvà, Francesc; Toledo, Rodrigo; Tabernero, Josep; Vivancos, Ana; Elez, Elena; Dienstmann, Rodrigo (Elsevier, 2023-06) -
Reporting reimbursement price decisions for onco-hematology drugs in Spain
Elvira-Martinez, David; Torres, Ferran; Puig, Gemma; Obach, Merce; Gay, Daniel; Vives, Roser; Tabernero, Josep (Frontiers Media, 2023-10-24) -
The impact of clinical and translational research on the quality of life during the metastatic colorectal cancer patient journey
Garcia Rodriguez, Ariadna; R Castells, Marta; Baraibar, Iosune; Ros, Javier; Saoudi Gonzalez, Nadia; Salvà, Francesc; Alcaraz Soler, Adriana; Tabernero, Josep; Elez, Elena (Frontiers Media, 2023-10-16) -
Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens
Bang, Yung-Jue; Ryu, Min-Hee; FAGNIEZ, Nathalie; Tabernero, Josep; Bedard, Philippe; Vieito , Maria (American Association for Cancer Research, 2023-08) -
Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumors
Le Tourneau, Christophe; Becker, Heiko; Claus, Rainer; Ricci, Francesco; Fritsch, R.; Elez, Elena; Tabernero, Josep (Elsevier, 2022-10) -
Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications
R Castells, Marta; Garcia Rodriguez, Ariadna; Alcaraz Soler, Adriana; Vega Cano, Kreina Sharela; Bueno Salazar, Sergio Andrés; Saoudi Gonzalez, Nadia; Salvà, Francesc; Ros, Javier; Baraibar, Iosune; Tabernero, Josep; Elez, Elena (MDPI, 2023-08-08)